Safety and Efficacy of CTAP101 Capsules for Treatment of SHPT and Vitamin D Insufficiency
Status: | Completed |
---|---|
Conditions: | Food Studies, Other Indications, Renal Impairment / Chronic Kidney Disease, Endocrine, Gastrointestinal |
Therapuetic Areas: | Endocrinology, Gastroenterology, Nephrology / Urology, Pharmacology / Toxicology, Other |
Healthy: | No |
Age Range: | 18 - 85 |
Updated: | 4/21/2016 |
Start Date: | November 2012 |
End Date: | September 2014 |
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy and Safety of CTAP101 Capsules to Treat Secondary Hyperparathyroidism in Subjects With Stage 3 or 4 Chronic Kidney Disease and Vitamin D Insufficiency
This study will evaluate the efficacy of CTAP101 Capsules versus placebo in reducing intact
parathyroid hormone (iPTH) by at least 30% from pretreatment baseline; safety and
tolerability of CTAP101 will also be evaluated
parathyroid hormone (iPTH) by at least 30% from pretreatment baseline; safety and
tolerability of CTAP101 will also be evaluated
Approximately 210 stage 3 or 4 CKD subjects with SHPT and vitamin D insufficiency will be
randomized to either CTAP101 Capsules or matching placebo for 6 months of treatment.
randomized to either CTAP101 Capsules or matching placebo for 6 months of treatment.
Inclusion Criteria:
1. Urinary albumin excretion ≤ 3000 mcg/mg of creatinine
2. Stage 3 or 4 CKD
3. Plasma iPTH: ≥ 85 pg/mL and < 500 pg/mL
4. Serum Ca: ≥ 8.4 mg/dL and < 9.8 mg/dL
5. Serum P: ≥ 2.0 mg/dL and < 5.0 mg/dL
6. Serum 25-hydroxyvitamin D: ≥ 10 ng/mL and < 30 ng/mL.
7. Stable dose of Vitamin D therapy ≤ 1600 IU/day and receiving same dose for at least 2
months
Exclusion Criteria:
1. History of kidney transplant or parathyroidectomy
2. Spot urine calcium:creatinine ratio > 0.2 (>200 mg/g Cr)
3. Current serious illness, such as malignancy, HIV, liver disease, cardiovascular event
or hepatitis
4. Currently on dialysis
5. Use of pharmacological dose of ergocalciferol or cholecalciferol (≥ 50,000 IU mcg per
month) during the study
We found this trial at
1
site
Click here to add this to my saved trials